Dr. Branko Palcic, founder of the BC Cancer Agency's Cancer Imaging Department, is the project manager. Dr. Haishan Zeng, senior scientist in the Integrative Oncology Department (Imaging Unit) of BC Cancer Agency, is the scientific advisor. Finally, Dr. Palcic assembled a team of engineers and scientists “with the expertise and knowledge to build the clinical prototype required for regulatory clinical studies.”

The company has given a brief paragraph explaining the two main contributors to the project:

“Dr. Branko Palcic holds a Ph.D. in Biophysics from McMaster University. He is currently both an Honorary Professor for the Department of Pathology and Laboratory Medicine, and was an Adjunct Professor for the Department of Physics, at the University of British Columbia. He was the founder and Senior Scientist of the Cancer Imaging Department, as well as the Director of Technology Development, with the BC Cancer Agency. Dr. Palcic's research interests include the development of methods for detection, diagnosis, and prognosis of early cancer and precancerous lesions.”

“Dr. Haishan Zeng holds a Ph.D. in Biophysics from the University of British Columbia. He is currently a Senior Scientist in the Integrative Oncology Department (Imaging Unit) at the BC Cancer Agency and also an Associate Professor of Dermatology and Skin Science at the University of British Columbia. Dr. Zeng's research focus is on the optical properties of biological tissues and light-tissue interaction and their applications in medical diagnosis and therapy and is named on numerous patents, including the patents that T-Ray Science has licensed from the BC Cancer Agency.”

T-RAY SCIENCE INC.
www.t-rayscience.com

 
Recommended for you

Xradia introduces new UltraRXM microscope

Plastic composite compression springs

NEMA launches podcasts on electroindustry topics

Micromem Technologies receives initial US$30 million purchase order

Machine vision cameras ideal for electronics, semiconductor and print inspection